{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:25:31Z","timestamp":1788805531897,"version":"build-2803163510"},"reference-count":61,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Urinary tract infections (UTIs) represent a common pathology among female patients, leading to overprescribing antibiotics, globally. The emergence of the COVID-19 pandemic has dramatically increased the incidence of this particular viral pneumonia with secondary bacterial superinfection, resulting in continuous therapeutic or prophylactic recommendations of antibiotic treatment; thus, an updated analysis of current antimicrobial resistance among uropathogens is mandatory. This cross-sectional retrospective study conducted in two university hospitals in Bucharest, Romania analyzed 2469 positive urine cultures, among two different periods of 6 months, before and during the COVID-19 pandemic. The most common pathogen was Escherichia coli 1505 (60.95%), followed by Klebsiella spp. 426 (17.25%). Enterococcus spp. was the leading Gram-positive pathogen 285 (11.54%). In gram negative bacteria, in almost all cases, an increased in resistance was observed, but the highest increase was represented by quinolones in Klebsiella spp., from 16.87% to 35.51% and Pseudomonas from 30.3% to 77.41%; a significant increase in resistance was also observed for carbapenems. Surprisingly, a decrease in resistance to Penicillin was observed in Enterococcus spp., but the overall tendency of increased resistance is also maintained for gram positive pathogens. The lack of data on the influence of the COVID-19 pandemic on uropathogens\u2019 resistance promotes these findings as important for every clinician treating UTIs and for every specialist in the medical field in promoting reasonable recommendations of antibiotic therapies.<\/jats:p>","DOI":"10.3390\/antibiotics11030376","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T11:46:47Z","timestamp":1646912807000},"page":"376","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Does the COVID Pandemic Modify the Antibiotic Resistance of Uropathogens in Female Patients? A New Storm?"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1005-7388","authenticated-orcid":false,"given":"Cristian","family":"Mare\u0219","sequence":"first","affiliation":[{"name":"Department of Urology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Urology, \u201cProf. Dr. Th. Burghele\u201d Clinical Hospital, 050659 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4496-1535","authenticated-orcid":false,"given":"R\u0103zvan-Cosmin","family":"Petca","sequence":"additional","affiliation":[{"name":"Department of Urology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Urology, \u201cProf. Dr. Th. Burghele\u201d Clinical Hospital, 050659 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4890-0978","authenticated-orcid":false,"given":"Aida","family":"Petca","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Obstetrics and Gynecology, Elias University Hospital, 011461 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6614-2816","authenticated-orcid":false,"given":"R\u0103zvan-Ionu\u021b","family":"Popescu","sequence":"additional","affiliation":[{"name":"Department of Urology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Urology, \u201cProf. Dr. Th. Burghele\u201d Clinical Hospital, 050659 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viorel","family":"Jinga","sequence":"additional","affiliation":[{"name":"Department of Urology, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Urology, \u201cProf. Dr. Th. Burghele\u201d Clinical Hospital, 050659 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1086\/318850","article-title":"Urinary tract infections: Disease panorama and challenges","volume":"183","author":"Stamm","year":"2001","journal-title":"J. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrurol.2010.190","article-title":"The epidemiology of urinary tract infection","volume":"7","author":"Foxman","year":"2010","journal-title":"Nat. Rev. Urol."},{"key":"ref_3","unstructured":"European Centre for Disease prevention and Control (2013). Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals, European Centre for Disease prevention and Control."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajog.2017.12.231","article-title":"Diagnosis and treatment of urinary tract infections across age groups","volume":"219","author":"Chu","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/S0002-9343(02)01054-9","article-title":"Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs","volume":"113","author":"Foxman","year":"2002","journal-title":"Am. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: Epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Walker","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2147\/IJGM.S11767","article-title":"Urinary tract infections in women: Etiology and treatment options","volume":"4","author":"Minardi","year":"2011","journal-title":"Int. J. Gen. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11908-013-0315-7","article-title":"Treatment of complicated urinary tract infections with an emphasis on drug-resistant Gram-negative uropathogens","volume":"15","author":"Levison","year":"2013","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"994","DOI":"10.31925\/farmacia.2019.6.9","article-title":"Antibiotic resistance profile of common uropathogens implicated in urinary tract infections in Romania","volume":"67","author":"Petca","year":"2019","journal-title":"Farmacia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1198-743x.2001.00326.x","article-title":"A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections","volume":"7","author":"Bouza","year":"2001","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chibelean, C.B., Petca, R.-C., Mares, C., Popescu, R.-I., Eniko, B., Mehedintu, C., and Petca, A. (2020). A clinical perspective on the antimicrobial resistance spectrum of uropathogens in a Romanian male population. Microorganisms, 8.","DOI":"10.3390\/microorganisms8060848"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kline, K.A., and Lewis, A.L. (2016). Gram-positive uropathogens, polymicrobial urinary tract infection, and the emerging microbiota of the urinary tract. Microbiol. Spectr., 4.","DOI":"10.1128\/microbiolspec.UTI-0012-2012"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/02813439608997082","article-title":"Symptomatic urinary tract infection in women in primary health care. Bacteriological, clinical and diagnostic aspects in relation to host response to infection","volume":"14","author":"Jellheden","year":"1996","journal-title":"Scand. J. Prim. Health Care"},{"key":"ref_14","unstructured":"Bonkat, G., Bartoletti, R., Bruyere, F., Cai, T., Geerlings, S.E., K\u00f6ves, B., Schubert, S., and Wagenlehner, F. (2021). EAU Guidelines on Urological Infections, European Association of Urology."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Petca, R.-C., Mare\u0219, C., Petca, A., Negoi\u021b\u0103, S., Popescu, R.-I., Bo\u021b, M., Barab\u00e1s, E., and Chibelean, C.B. (2020). Spectrum and Antibiotic Resistance of Uropathogens in Romanian Females. Antibiotics, 9.","DOI":"10.3390\/antibiotics9080472"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2471\/BLT.20.268573","article-title":"Tackling antimicrobial resistance in the COVID-19 pandemic","volume":"98","author":"Getahun","year":"2020","journal-title":"Bull. World Health Organ"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.4269\/ajtmh.21-0603","article-title":"Antibiotic overuse for COVID-19: Are we adding insult to injury?","volume":"105","author":"Abdela","year":"2021","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_18","first-page":"393","article-title":"Medicaci\u00f3n prehospitalaria en pacientes hospitalizados por COVID-19 en un hospital p\u00fablico de Lima-Per\u00fa","volume":"37","year":"2020","journal-title":"Acta M\u00e9dica Peru."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Gasperini, B., Cherubini, A., Lucarelli, M., Espinosa, E., and Prospero, E. (2021). Multidrug-resistant bacterial infections in geriatric hospitalized patients before and after the COVID-19 outbreak: Results from a retrospective observational study in two geriatric wards. Antibiotics, 10.","DOI":"10.3390\/antibiotics10010095"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Petca, R.-C., Negoi\u021b\u0103, S., Mare\u0219, C., Petca, A., Popescu, R.-I., and Chibelean, C.B. (2021). Heterogeneity of antibiotics multidrug-resistance profile of uropathogens in Romanian population. Antibiotics, 10.","DOI":"10.3390\/antibiotics10050523"},{"key":"ref_21","unstructured":"O\u2019Neill, J. (2014). Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations, HM Government Welcome Trust. Review on Antimicrobial Resistance."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejogrb.2011.01.028","article-title":"Urinary tract infections in women","volume":"156","author":"Salvatore","year":"2011","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","article-title":"Urinary tract infection syndromes: Occurrence, recurrence, bacteriology, risk factors, and disease burden","volume":"28","author":"Foxman","year":"2014","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJM199608153350703","article-title":"A prospective study of risk factors for symptomatic urinary tract infection in young women","volume":"335","author":"Hooton","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/315827","article-title":"Risk factors for recurrent urinary tract infection in young women","volume":"182","author":"Scholes","year":"2000","journal-title":"J. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1756287218814382","DOI":"10.1177\/1756287218814382","article-title":"Risk factors and predisposing conditions for urinary tract infection","volume":"11","author":"Storme","year":"2019","journal-title":"Ther. Adv. Urol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s15010-019-01361-y","article-title":"Active surveillance of antibiotic resistance patterns in urinary tract infections in primary care in Switzerland","volume":"47","author":"Plate","year":"2019","journal-title":"Infection"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Al-Zahrani, J., Al Dossari, K., Gabr, A.H., Ahmed, A.F., Al Shahrani, S.A., and Al-Ghamdi, S. (2019). Antimicrobial resistance patterns of uropathogens isolated from adult women with acute uncomplicated cystitis. BMC Microbiol., 19.","DOI":"10.1186\/s12866-019-1612-6"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kwon, K.T., Kim, B., Ryu, S.-Y., Wie, S.-H., Kim, J., Jo, H.-U., Park, S.Y., Hong, K.-W., Kim, H.I., and Kim, H.A. (2020). Changes in clinical characteristics of community-acquired acute pyelonephritis and antimicrobial resistance of uropathogenic Escherichia coli in South Korea in the past decade. Antibiotics, 9.","DOI":"10.3390\/antibiotics9090617"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/320880","article-title":"Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: A nationwide analysis","volume":"33","author":"Gupta","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kubone, P.Z., Mlisana, K.P., Govinden, U., Abia, A.L.K., and Essack, S.Y. (2020). Antibiotic susceptibility and molecular characterization of uropathogenic Escherichia coli associated with community-acquired urinary tract infections in urban and rural settings in South Africa. Trop. Med. Infect. Dis., 5.","DOI":"10.3390\/tropicalmed5040176"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gajd\u00e1cs, M., B\u00e1tori, Z., \u00c1br\u00f3k, M., L\u00e1z\u00e1r, A., and Buri\u00e1n, K. (2020). Characterization of resistance in gram-negative urinary isolates using existing and novel indicators of clinical relevance: A 10-year data analysis. Life, 10.","DOI":"10.1038\/s41598-020-74834-y"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000504415","article-title":"Changes in antimicrobial resistance of urinary tract infections in adult patients over a 5-year period","volume":"104","author":"Caskurlu","year":"2020","journal-title":"Urol. Int."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Hrbacek, J., Cermak, P., and Zachoval, R. (2020). Current antibiotic resistance trends of uropathogens in Central Europe: Survey from a tertiary hospital urology department 2011\u20132019. Antibiotics, 9.","DOI":"10.3390\/antibiotics9090630"},{"key":"ref_35","first-page":"1","article-title":"Gram-positive uropathogens: Empirical treatment and emerging antimicrobial resistance","volume":"4","author":"Urmi","year":"2019","journal-title":"Biomed Res. Clin. Prac."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2147\/IDR.S200988","article-title":"Comparative study of antimicrobial resistance and biofilm formation among Gram-positive uropathogens isolated from community acquired urinary tract infections and catheter-associated urinary tract infections","volume":"12","author":"Shrestha","year":"2019","journal-title":"Infect. Dru. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s10096-016-2673-1","article-title":"Etiology and antibiotic susceptibility of bacterial pathogens responsible for community-acquired urinary tract infections in Poland","volume":"35","author":"Stefaniuk","year":"2016","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1099\/jmm.0.000498","article-title":"Spectrum and antibiotic resistance of uropathogens between 2004 and 2015 in a tertiary care hospital in Hungary","volume":"66","author":"Magyar","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Gajd\u00e1cs, M., \u00c1br\u00f3k, M., L\u00e1z\u00e1r, A., and Buri\u00e1n, K. (2019). Comparative epidemiology and resistance trends of common urinary pathogens in a tertiary-care hospital: A 10-year surveillance study. Medicina, 55.","DOI":"10.3390\/medicina55070356"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e5310716161","DOI":"10.33448\/rsd-v10i7.16161","article-title":"Main bacteria found in urine cultures of patients with urinary tract infections (UTI) and their resistance profile to antimicrobials","volume":"10","author":"Oliveira","year":"2021","journal-title":"Res. Soc. Dev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"17658","DOI":"10.1038\/s41598-020-74834-y","article-title":"Increasing relevance of Gram-positive cocci in urinary tract infections: A 10-year analysis of their prevalence and resistance trends","volume":"10","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e64139","DOI":"10.7554\/eLife.64139","article-title":"Antimicrobial resistance and COVID-19: Intersections and implications","volume":"10","author":"Knight","year":"2021","journal-title":"eLife"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance-the need for global solutions","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.cmi.2020.07.016","article-title":"Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta- analysis","volume":"26","author":"Langford","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jinf.2020.05.046","article-title":"Co-infections in people with COVID-19: A systematic review and meta-analysis","volume":"81","author":"Lansbury","year":"2020","journal-title":"J. Infect."},{"key":"ref_46","unstructured":"World Health Organization (2021). COVID-19 Clinical Management: Living Guidance, 25 January 2021, World Health Organization."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: Rapid review and meta-analysis","volume":"27","author":"Langford","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jiph.2020.10.018","article-title":"The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics","volume":"14","author":"Ukuhor","year":"2021","journal-title":"J. Infect. Public Health"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.arcmed.2020.10.010","article-title":"COVID-19: Clouds over the antimicrobial resistance landscape","volume":"52","year":"2021","journal-title":"Arch. Med. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"106324","DOI":"10.1016\/j.ijantimicag.2021.106324","article-title":"Increased antimicrobial resistance during the COVID-19 pandemic","volume":"57","author":"Lai","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajic.2021.09.018","article-title":"Impact of the COVID-19 pandemic on the incidence of multidrug-resistant bacterial infections in an acute care hospital in Brazil","volume":"50","author":"Polly","year":"2021","journal-title":"Am. J. Infect. Control"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"572","DOI":"10.7196\/SAMJ.2020.v110i7.14917","article-title":"Collateral damage of the COVID-19 pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes?","volume":"110","author":"Chibabhai","year":"2020","journal-title":"S. Afr. Med. J."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Milas, S., Poncelet, A., Buttafuoco, F., Pardo, A., Lali, S.E., and Cherifi, S. (2021). Antibiotic use in patients with Coronavirus disease 2019 (COVID-19): Outcomes and associated factors. Acta Clin. Belg., 1\u20139.","DOI":"10.1080\/17843286.2021.1916300"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"dlaa051","DOI":"10.1093\/jacamr\/dlaa051","article-title":"CON: COVID-19 will not result in increased antimicrobial resistance prevalence","volume":"2","author":"Collignon","year":"2020","journal-title":"JAC Antimicrob. Resist."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Moya, C., and Maicas, S. (2020). Antimicrobial resistance in Klebsiella pneumoniae strains: Mechanisms and outbreaks. Proceedings, 66.","DOI":"10.3390\/proceedings2020066011"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"ref_57","unstructured":"Benea, E.O., Gavriliu, L.C., Popescu, C., and Popescu, G.A. (2018). Ghidul Angelescu. Terapie Antimicrobiana 2018, Editura Bucuresti. [3rd ed.]."},{"key":"ref_58","unstructured":"World Health Organization (2000). Guidelines for the Collection of Clinical Specimens during Field Investigation of Outbreaks, World Health Organization."},{"key":"ref_59","unstructured":"Clinical and Laboratory Standards Institute\u00ae (CLSI) (2020, May 10). M 100 Performance Standards for Antimicrobial Susceptibility Testing, 28th ed. Available online: https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m100\/."},{"key":"ref_60","unstructured":"(2021, December 10). The European Committee on Antimicrobial Susceptibility Testing. 2017. Disk Diffusion Method for Antimicrobial Susceptibility Testing\u2014Version 6.0. Available online: http:\/\/www.eucast.org\/ast_of_bacteria\/."},{"key":"ref_61","unstructured":"World Health Organization (2020). Global Antimicrobial Resistance Surveillance System (GLASS) Report: Early Implementation 2020, World Health Organization."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/3\/376\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:34:31Z","timestamp":1760135671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/11\/3\/376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":61,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["antibiotics11030376"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics11030376","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]}}}